Invention Grant
- Patent Title: Stabilized pre-fusion RSV F proteins
-
Application No.: US17249372Application Date: 2021-03-01
-
Publication No.: US11759514B2Publication Date: 2023-09-19
- Inventor: Johannes Petrus Maria Langedijk
- Applicant: Janssen Vaccines & Prevention B.V.
- Applicant Address: NL Leiden
- Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee Address: NL Leiden
- Agency: Ice Miller LLP
- Priority: EP 172008 2016.05.30
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/155 ; C07K14/005 ; C07K14/135 ; C12N7/00
Abstract:
Stable pre-fusion respiratory syncytial virus (RSV) F proteins, immunogenic compositions including the proteins and uses thereof for the prevention and/or treatment of RSV infection are described.
Public/Granted literature
- US20210205440A1 STABILIZED PRE-FUSION RSV F PROTEINS Public/Granted day:2021-07-08
Information query
